Colorectal Cancer Market - Forecast(2020 - 2025)

Report Code: HCR 0127 Report Format: PDF + Excel (Delivery in 48 Hrs)
Colorectal Cancer Market Overview
Colorectal Cancer Market size is forecast to reach $31,237m by 2025 from $26,269m in 2019, growing at a CAGR of 3.0% during the forecast period 2020-2025. Rising prevalence of colorectal cancer owing to the unhealthy food habits and odd food consumption timings of individuals are factors driving the growth of the market. These factors add to the risk of an individual to growth of tumors that would lead to cancer. Increasing geriatric population base and growing number of clinical trials to market new drugs is set to further enhance the overall market demand of Colorectal Cancer during the forecast period 2020-2025. 

Report Coverage
The report: “Colorectal Cancer Market Forecast (2020-2025)”, by IndustryARC, covers an in-depth analysis of the following segments of the Colorectal Cancer market. 

By Procedure: Colectomy, Colostomy, Endoscopic Surgery, Hemorrhoidectomy, Ileal Pouch Anal Anastomosis (J-Pouch), Inflammatory Bowel Disease (IBD) Surgery, Internal Sphincterotomy, Rectopexy, Others
By Drugs: Chemotherapy Drugs, Immunotherapy, Others
By End Use: Hospitals & Ambulatory Surgical Centers, Others
By Geography: North America, Europe, Asia Pacific, Rest of the World

Key Takeaways
  • North America dominated the Colorectal Cancer market owing to the growing cases in the region. Excess consumption of unhealthy food and carbonated soft drinks in the region is set to add to growth of colorectal cancer cases in the market. The Colorectal Cancer market scope for different regions will be provided in the final report.
  • The increasing prevalence of colorectal cancer among individuals and the growing health awareness among masses is likely to aid in the market growth of Colorectal Cancer.
  • Detailed analysis on the Strength, Weakness and opportunities of the prominent players operating in the market will be provided in the Colorectal Cancer market report.
  • High cost of Colorectal Cancer surgeries and drugs is set to create hurdles for the Colorectal Cancer market.

By Procedure Type- Segment Analysis
The Colectomy segment held the largest share in the Colorectal Cancer market in 2019 and is estimated to grow at a CAGR of 2.3% during the forecast period 2020-2025. The growth in this segment can be attributed to growing cases of colorectal cancer among individuals.  Colectomy is a kind of cancer surgery that deals with the removal of the cancer affected portion of the colon. Colectomy surgery is bifurcated as  partial colectomy and total colectomy where partial colectomy happens when only a part of colon is removed and total colectomy happens when all of the colon itself is removed. As per Health System Consortium Association the number of patients suffering from colorectal cancer is 60% to 80% in U.S. and the number of colectomies performed in 2019 was 300,000 and is estimated to be rising every year. Thus it is observed that there is an increase in patients suffering from colorectal cancer globally, which in turn increases the need for colectomy surgeries. Colostomy is estimated to be the fastest growing segment and is set to register the highest CAGR during the forecast period 2020-2025.

By End Use - Segment Analysis
Hospitals & Ambulatory Surgical Centers segment of Colorectal Cancer market in 2019. The Ambulatory Surgical Center (ASC) is an important part of the practice of gastroenterology, providing a safe, patient friendly and cost-effective environment for the provision of medical services such as colorectal cancer screening colonoscopy, for patients of all ages. Common types of treatment for colorectal cancer in hospitals are performed in surgical therapy, radiation therapy, therapies using medication, chemotherapy, targeted therapy and Immunotherapy.

By Geography - Segment Analysis
North America dominated the colorectal cancer market with a share of more than 37%, followed by Europe. U.S. held the major revenue share in North America region. This is owing to the rising awareness among consumers about diagnosis and treatment of colorectal cancer. The condition is considered as the second most common cause of death in the U.S. Excess consumption of unhealthy diet and carbonated soft drinks in this region are key factors that has led to the growth of Colorectal Cancer Market in this region. Rising government support for the development of colorectal cancer surgery procedures and drugs has boosted the growth of the market in this region. New advances in technology, approval for new drugs by the FDA and presence of key players that are in the market are also supporting the growth of the market.

Drivers – Colorectal Cancer Market

  • Growing Prevalence of Colorectal Cancer
According to Cancer.org, the lifetime risk of developing colorectal cancer is about 1 in 23 (4.4%) for men and 1 in 25 (4.1%) for women. This risk is slightly lower in women than in men. Colorectal cancer is the third most commonly occurring cancer in men and the second most commonly occurring cancer in women. There were over 1.8 million new cases in 2018. The 5-year survival rate of people with localized stage colorectal cancer is 90%. About 39% of patients are diagnosed at this early stage. If the cancer has spread to surrounding tissues or organs and/or the regional lymph nodes, the 5-year survival rate is 71%. The main types of treatment for colon and rectal cancer are surgery, radiation therapy, chemotherapy, immunotherapy, and targeted therapy. Depending on the stage of the cancer, two or more of these types of treatment is set to combine at the same time or used one after another. Following more regulations on healthcare and rising healthcare expenditure, the market growth is driven by growing prevalence.
 
  • Growing Health Awareness among Masses 
Most participants consider that their health status is good. About 53% exercise regularly. But about 32% of the participants are suffering from some types of cancer. All of them consider that treatments of cancer is very important. But mediclaim policies are held by only 41% of them. Increasing awareness and educating the masses on hygiene, preventive health measures, timely diagnosis and, above all, the importance of completing doctor prescribed treatment are done by patients in recent years. Health Awareness Campaigns are one of the most functional elements in health system that push people to create that big change to eradicate or lessen the unhealthy impact the health issue. Healthcare Awareness Campaigns are meat to trigger that action of change, promise a healthier society with long standing impact in the society.
Major players in biotechnology are investing in smaller players and enhancing their products using the technology acquired. Some instances for this are Pfizer acquisition of Medivation, Takeda Pharmaceuticals with Ariad Pharmaceuticals, and many more.

Challenges – Colorectal Cancer Market

  • High-cost involved with treatments 
The mean total colon cancer cost per Medicare patient is estimated to be $29,196. The method can be applied to longitudinal data to estimate long term costs of cancer from inception where incident patients are identified from a tumor registry. Screening can reduce mortality significantly, although the most appropriate method is still under debate. Observational studies have revealed that lifestyle measures are also supposed to be beneficial for prevention of colorectal cancer. Surgery is still the most effective treatment modality for colorectal cancer. The survival benefits of chemotherapy are only modest. Hence it causes confusion and doubts about costs and survival chances. 

Colorectal Cancer Industry Outlook
Product launches, mergers and acquisitions, joint ventures and R&D activities are key strategies adopted by players in the wearable blood pressure monitor market. In 2019, Colorectal Cancer market share is consolidated by the top ten players present in the market. Colorectal Cancer top 10 companies are Amgen Inc., Roche Holding AG, Pfizer Inc., Eli Lilly and Company, Bristol Myers Squibb Company, Clinical Genomics Technologies Pty Ltd., Taiho Oncology Inc., Sanofi SA, Bayer Inc. and Merck Group, among others. 

Acquisitions/Product Launches
  • In June 2017, FDA approved Vectibix® for the use in wild type RAS Metastatic Colorectal Cancer. FDA approved very first multigene, next-generation sequencing-based test to identify the RAS mutation status of a patient's tumor.
  • In 2018, Merck Group collaborated with SFJ Pharmaceuticals Group to develop abituzumab as a first-line treatment for metastatic colorectal cancer (mCRC) in combination with Erbitux® and chemotherapy.

1. Colorectal Cancer Market Overview
    1.1. Definitions and Scope
2. Colorectal Cancer Market - Executive Summary
    2.1. Market Revenue, Market Size and Key Trends by Company
    2.2. Key trends by Procedure Type
    2.3. Key trends by End Use
    2.4. Key trends by Geography
3. Colorectal Cancer Market - Comparative Analysis 
    3.1. Product Benchmarking
    3.2. Top 5 Financials Analysis
    3.3. Market Share Analysis – Key Companies
4. Colorectal Cancer Market - Startup Companies Scenario (Premium)
    4.1. Key Startup Company Analysis by
        4.1.1. Investment
        4.1.2. Revenue
        4.1.3. Venture Capital and Funding Scenario
5. Colorectal Cancer Market – Industry Market Entry Scenario Premium (Premium)
    5.1. Regulatory Framework Overview
    5.2. New Business and Ease of Doing business index
    5.3. Case Studies of Successful Ventures
6. Colorectal Cancer Market Forces
    6.1. Market Drivers
    6.2. Market Constraints & Challenges
    6.3. Market Opportunities
    6.4. Porters five force model
        6.4.1. Bargaining power of suppliers
        6.4.2. Bargaining powers of customers
        6.4.3. Threat of new entrants
        6.4.4. Rivalry among existing players
        6.4.5. Threat of substitutes 
7. Colorectal Cancer Market - By Strategic Analysis 
    7.1. Value Chain Analysis
    7.2. Pricing Analysis
    7.3. Market Life Cycle Analysis
8. Colorectal Cancer Market – By Procedure Types (Market Size — $Million/$Billion)
    8.1. Colectomy
    8.2. Colostomy
    8.3. Endoscopic Surgery
    8.4. Hemorrhoidectomy
    8.5. Ileal Pouch Anal Anastomosis (J-Pouch)
    8.6. Inflammatory Bowel Disease (IBD) Surgery
    8.7. Internal Sphincterotomy
    8.8. Rectopexy
    8.9. Others
9. Colorectal Cancer Market- By Drugs (Market Size — $Million/$Billion)
    9.1. Chemotherapy Drugs
        9.1.1. Antimetabolites
            9.1.1.1. Fluorouracil (Adrucil)
            9.1.1.2. Capecitabine (Xeloda)
        9.1.2. Alkylating Agent - Oxaliplatin (Eloxatin)
        9.1.3. Others
    9.2. Immunotherapy
        9.2.1. Monoclonal Antibodies
        9.2.2. Bevacizumab (Avastin)
        9.2.3. Cetuximab (Erbitux)
        9.2.4. Panitumumab (Vectibix)
    9.3. Others
10. Colorectal Cancer Market - By End Use (Market Size — $Million/$Billion)
    10.1. Hospitals & Ambulatory Surgical Centers
    10.2. Others
11. Colorectal Cancer Market - By Geography (Market Size — $Million/$Billion)
    11.1. North America 
        11.1.1. U.S. 
        11.1.2. Canada 
        11.1.3. Mexico  
    11.2. Europe 
        11.2.1. U.K 
        11.2.2. Germany 
        11.2.3. Italy 
        11.2.4. France
        11.2.5. Netherlands
        11.2.6. Belgium
        11.2.7. Denmark
        11.2.8. Spain
        11.2.9. Rest of Europe
    11.3. Asia-Pacific
        11.3.1. China
        11.3.2. Australia & New Zealand
        11.3.3. India
        11.3.4. Japan
        11.3.5. South Korea
        11.3.6. Rest of Asia Pacific
    11.4. Rest of World
        11.4.1. Africa
        11.4.2. Middle East
        11.4.3. South America
12. Colorectal Cancer Market- Entropy
13. Company Profiles (Overview, Financials, Developments, Product Portfolio)
    13.1. Company 1
    13.2. Company 2
    13.3. Company 3
    13.4. Company 4
    13.5. Company 5
    13.6. Company 6
    13.7. Company 7
    13.8. Company 8
    13.9. Company 9
    13.10. Company 10 and more
"*Financials would be provided on a best efforts basis for private companies"

List of Tables

Table 1: Colorectal Cancer Market Overview 2019-2024
Table 2: Colorectal Cancer Market Leader Analysis 2018-2019 (US$)
Table 3: Colorectal Cancer MarketProduct Analysis 2018-2019 (US$)
Table 4: Colorectal Cancer MarketEnd User Analysis 2018-2019 (US$)
Table 5: Colorectal Cancer MarketPatent Analysis 2013-2018* (US$)
Table 6: Colorectal Cancer MarketFinancial Analysis 2018-2019 (US$)
Table 7: Colorectal Cancer Market Driver Analysis 2018-2019 (US$)
Table 8: Colorectal Cancer MarketChallenges Analysis 2018-2019 (US$)
Table 9: Colorectal Cancer MarketConstraint Analysis 2018-2019 (US$)
Table 10: Colorectal Cancer Market Supplier Bargaining Power Analysis 2018-2019 (US$)
Table 11: Colorectal Cancer Market Buyer Bargaining Power Analysis 2018-2019 (US$)
Table 12: Colorectal Cancer Market Threat of Substitutes Analysis 2018-2019 (US$)
Table 13: Colorectal Cancer Market Threat of New Entrants Analysis 2018-2019 (US$)
Table 14: Colorectal Cancer Market Degree of Competition Analysis 2018-2019 (US$)
Table 15: Colorectal Cancer MarketValue Chain Analysis 2018-2019 (US$)
Table 16: Colorectal Cancer MarketPricing Analysis 2019-2024 (US$)
Table 17: Colorectal Cancer MarketOpportunities Analysis 2019-2024 (US$)
Table 18: Colorectal Cancer MarketProduct Life Cycle Analysis 2019-2024 (US$)
Table 19: Colorectal Cancer MarketSupplier Analysis 2018-2019 (US$)
Table 20: Colorectal Cancer MarketDistributor Analysis 2018-2019 (US$)
Table 21: Colorectal Cancer Market Trend Analysis 2018-2019 (US$)
Table 22: Colorectal Cancer Market Size 2018 (US$)
Table 23: Colorectal Cancer Market Forecast Analysis 2019-2024 (US$)
Table 24: Colorectal Cancer Market Sales Forecast Analysis 2019-2024 (Units)
Table 25: Colorectal Cancer Market, Revenue & Volume,By Testing & Diagnosis , 2019-2024 ($)
Table 26: Colorectal Cancer MarketBy Testing & Diagnosis , Revenue & Volume,By Macroscopy , 2019-2024 ($)
Table 27: Colorectal Cancer MarketBy Testing & Diagnosis , Revenue & Volume,By Microscopy , 2019-2024 ($)
Table 28: Colorectal Cancer MarketBy Testing & Diagnosis , Revenue & Volume,By Immunochemistry , 2019-2024 ($)
Table 29: Colorectal Cancer MarketBy Testing & Diagnosis , Revenue & Volume,By Staging , 2019-2024 ($)
Table 30: Colorectal Cancer MarketBy Testing & Diagnosis , Revenue & Volume,By Tumor Budding. , 2019-2024 ($)
Table 31: Colorectal Cancer Market, Revenue & Volume,By Therapies & Drugs, 2019-2024 ($)
Table 32: Colorectal Cancer MarketBy Therapies & Drugs, Revenue & Volume,By Surgery , 2019-2024 ($)
Table 33: Colorectal Cancer MarketBy Therapies & Drugs, Revenue & Volume,By Chemotherapy , 2019-2024 ($)
Table 34: Colorectal Cancer MarketBy Therapies & Drugs, Revenue & Volume,By Antimetabolites , 2019-2024 ($)
Table 35: Colorectal Cancer MarketBy Therapies & Drugs, Revenue & Volume,By Radiation Therapy , 2019-2024 ($)
Table 36: Colorectal Cancer MarketBy Therapies & Drugs, Revenue & Volume,By Immunotherapy , 2019-2024 ($)
Table 37: North America Colorectal Cancer Market, Revenue & Volume,By Testing & Diagnosis , 2019-2024 ($)
Table 38: North America Colorectal Cancer Market, Revenue & Volume,By Therapies & Drugs, 2019-2024 ($)
Table 39: South america Colorectal Cancer Market, Revenue & Volume,By Testing & Diagnosis , 2019-2024 ($)
Table 40: South america Colorectal Cancer Market, Revenue & Volume,By Therapies & Drugs, 2019-2024 ($)
Table 41: Europe Colorectal Cancer Market, Revenue & Volume,By Testing & Diagnosis , 2019-2024 ($)
Table 42: Europe Colorectal Cancer Market, Revenue & Volume,By Therapies & Drugs, 2019-2024 ($)
Table 43: APAC Colorectal Cancer Market, Revenue & Volume,By Testing & Diagnosis , 2019-2024 ($)
Table 44: APAC Colorectal Cancer Market, Revenue & Volume,By Therapies & Drugs, 2019-2024 ($)
Table 45: Middle East & Africa Colorectal Cancer Market, Revenue & Volume,By Testing & Diagnosis , 2019-2024 ($)
Table 46: Middle East & Africa Colorectal Cancer Market, Revenue & Volume,By Therapies & Drugs, 2019-2024 ($)
Table 47: Russia Colorectal Cancer Market, Revenue & Volume,By Testing & Diagnosis , 2019-2024 ($)
Table 48: Russia Colorectal Cancer Market, Revenue & Volume,By Therapies & Drugs, 2019-2024 ($)
Table 49: Israel Colorectal Cancer Market, Revenue & Volume,By Testing & Diagnosis , 2019-2024 ($)
Table 50: Israel Colorectal Cancer Market, Revenue & Volume,By Therapies & Drugs, 2019-2024 ($)
Table 51: Top Companies 2018 (US$)Colorectal Cancer Market, Revenue & Volume,,
Table 52: Product Launch 2018-2019Colorectal Cancer Market, Revenue & Volume,,
Table 53: Mergers & Acquistions 2018-2019Colorectal Cancer Market, Revenue & Volume,,

List of Figures

Figure 1: Overview of Colorectal Cancer Market 2019-2024
Figure 2: Market Share Analysis for Colorectal Cancer Market 2018 (US$)
Figure 3: Product Comparison in Colorectal Cancer Market 2018-2019 (US$)
Figure 4: End User Profile for Colorectal Cancer Market 2018-2019 (US$)
Figure 5: Patent Application and Grant in Colorectal Cancer Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Colorectal Cancer Market 2018-2019 (US$)
Figure 7: Market Entry Strategy in Colorectal Cancer Market 2018-2019
Figure 8: Ecosystem Analysis in Colorectal Cancer Market2018
Figure 9: Average Selling Price in Colorectal Cancer Market 2019-2024
Figure 10: Top Opportunites in Colorectal Cancer Market 2018-2019
Figure 11: Market Life Cycle Analysis in Colorectal Cancer Market
Figure 12: GlobalBy Testing & Diagnosis Colorectal Cancer Market Revenue, 2019-2024 ($)
Figure 13: GlobalBy Therapies & DrugsColorectal Cancer Market Revenue, 2019-2024 ($)
Figure 14: Global Colorectal Cancer Market - By Geography
Figure 15: Global Colorectal Cancer Market Value & Volume, By Geography, 2019-2024 ($) 
Figure 16: Global Colorectal Cancer Market CAGR, By Geography, 2019-2024 (%)
Figure 17: North America Colorectal Cancer Market Value & Volume, 2019-2024 ($)
Figure 18: US Colorectal Cancer Market Value & Volume, 2019-2024 ($)
Figure 19: US GDP and Population, 2018-2019 ($)
Figure 20: US GDP – Composition of 2018, By Sector of Origin
Figure 21: US Export and Import Value & Volume, 2018-2019 ($)
Figure 22: Canada Colorectal Cancer Market Value & Volume, 2019-2024 ($)
Figure 23: Canada GDP and Population, 2018-2019 ($)
Figure 24: Canada GDP – Composition of 2018, By Sector of Origin
Figure 25: Canada Export and Import Value & Volume, 2018-2019 ($)
Figure 26: Mexico Colorectal Cancer Market Value & Volume, 2019-2024 ($)
Figure 27: Mexico GDP and Population, 2018-2019 ($)
Figure 28: Mexico GDP – Composition of 2018, By Sector of Origin
Figure 29: Mexico Export and Import Value & Volume, 2018-2019 ($)
Figure 30: South America Colorectal Cancer MarketSouth America 3D Printing Market Value & Volume, 2019-2024 ($)
Figure 31: Brazil Colorectal Cancer Market Value & Volume, 2019-2024 ($)
Figure 32: Brazil GDP and Population, 2018-2019 ($)
Figure 33: Brazil GDP – Composition of 2018, By Sector of Origin
Figure 34: Brazil Export and Import Value & Volume, 2018-2019 ($)
Figure 35: Venezuela Colorectal Cancer Market Value & Volume, 2019-2024 ($)
Figure 36: Venezuela GDP and Population, 2018-2019 ($)
Figure 37: Venezuela GDP – Composition of 2018, By Sector of Origin
Figure 38: Venezuela Export and Import Value & Volume, 2018-2019 ($)
Figure 39: Argentina Colorectal Cancer Market Value & Volume, 2019-2024 ($)
Figure 40: Argentina GDP and Population, 2018-2019 ($)
Figure 41: Argentina GDP – Composition of 2018, By Sector of Origin
Figure 42: Argentina Export and Import Value & Volume, 2018-2019 ($)
Figure 43: Ecuador Colorectal Cancer Market Value & Volume, 2019-2024 ($)
Figure 44: Ecuador GDP and Population, 2018-2019 ($)
Figure 45: Ecuador GDP – Composition of 2018, By Sector of Origin
Figure 46: Ecuador Export and Import Value & Volume, 2018-2019 ($)
Figure 47: Peru Colorectal Cancer Market Value & Volume, 2019-2024 ($)
Figure 48: Peru GDP and Population, 2018-2019 ($)
Figure 49: Peru GDP – Composition of 2018, By Sector of Origin
Figure 50: Peru Export and Import Value & Volume, 2018-2019 ($)
Figure 51: Colombia Colorectal Cancer Market Value & Volume, 2019-2024 ($)
Figure 52: Colombia GDP and Population, 2018-2019 ($)
Figure 53: Colombia GDP – Composition of 2018, By Sector of Origin
Figure 54: Colombia Export and Import Value & Volume, 2018-2019 ($)
Figure 55: Costa Rica Colorectal Cancer MarketCosta Rica 3D Printing Market Value & Volume, 2019-2024 ($)
Figure 56: Costa Rica GDP and Population, 2018-2019 ($)
Figure 57: Costa Rica GDP – Composition of 2018, By Sector of Origin
Figure 58: Costa Rica Export and Import Value & Volume, 2018-2019 ($)
Figure 59: Europe Colorectal Cancer Market Value & Volume, 2019-2024 ($)
Figure 60: U.K Colorectal Cancer Market Value & Volume, 2019-2024 ($)
Figure 61: U.K GDP and Population, 2018-2019 ($)
Figure 62: U.K GDP – Composition of 2018, By Sector of Origin
Figure 63: U.K Export and Import Value & Volume, 2018-2019 ($)
Figure 64: Germany Colorectal Cancer Market Value & Volume, 2019-2024 ($)
Figure 65: Germany GDP and Population, 2018-2019 ($)
Figure 66: Germany GDP – Composition of 2018, By Sector of Origin
Figure 67: Germany Export and Import Value & Volume, 2018-2019 ($)
Figure 68: Italy Colorectal Cancer Market Value & Volume, 2019-2024 ($)
Figure 69: Italy GDP and Population, 2018-2019 ($)
Figure 70: Italy GDP – Composition of 2018, By Sector of Origin
Figure 71: Italy Export and Import Value & Volume, 2018-2019 ($)
Figure 72: France Colorectal Cancer Market Value & Volume, 2019-2024 ($)
Figure 73: France GDP and Population, 2018-2019 ($)
Figure 74: France GDP – Composition of 2018, By Sector of Origin
Figure 75: France Export and Import Value & Volume, 2018-2019 ($)
Figure 76: Netherlands Colorectal Cancer Market Value & Volume, 2019-2024 ($)
Figure 77: Netherlands GDP and Population, 2018-2019 ($)
Figure 78: Netherlands GDP – Composition of 2018, By Sector of Origin
Figure 79: Netherlands Export and Import Value & Volume, 2018-2019 ($)
Figure 80: Belgium Colorectal Cancer Market Value & Volume, 2019-2024 ($)
Figure 81: Belgium GDP and Population, 2018-2019 ($)
Figure 82: Belgium GDP – Composition of 2018, By Sector of Origin
Figure 83: Belgium Export and Import Value & Volume, 2018-2019 ($)
Figure 84: Spain Colorectal Cancer Market Value & Volume, 2019-2024 ($)
Figure 85: Spain GDP and Population, 2018-2019 ($)
Figure 86: Spain GDP – Composition of 2018, By Sector of Origin
Figure 87: Spain Export and Import Value & Volume, 2018-2019 ($)
Figure 88: Denmark Colorectal Cancer Market Value & Volume, 2019-2024 ($)
Figure 89: Denmark GDP and Population, 2018-2019 ($)
Figure 90: Denmark GDP – Composition of 2018, By Sector of Origin
Figure 91: Denmark Export and Import Value & Volume, 2018-2019 ($)
Figure 92: APAC Colorectal Cancer Market Value & Volume, 2019-2024 ($)
Figure 93: China Colorectal Cancer MarketValue & Volume, 2019-2024
Figure 94: China GDP and Population, 2018-2019 ($)
Figure 95: China GDP – Composition of 2018, By Sector of Origin
Figure 96: China Export and Import Value & Volume, 2018-2019 ($)Colorectal Cancer MarketChina Export and Import Value & Volume, 2018-2019 ($)
Figure 97: Australia Colorectal Cancer Market Value & Volume, 2019-2024 ($)
Figure 98: Australia GDP and Population, 2018-2019 ($)
Figure 99: Australia GDP – Composition of 2018, By Sector of Origin
Figure 100: Australia Export and Import Value & Volume, 2018-2019 ($)
Figure 101: South Korea Colorectal Cancer Market Value & Volume, 2019-2024 ($)
Figure 102: South Korea GDP and Population, 2018-2019 ($)
Figure 103: South Korea GDP – Composition of 2018, By Sector of Origin
Figure 104: South Korea Export and Import Value & Volume, 2018-2019 ($)
Figure 105: India Colorectal Cancer Market Value & Volume, 2019-2024 ($)
Figure 106: India GDP and Population, 2018-2019 ($)
Figure 107: India GDP – Composition of 2018, By Sector of Origin
Figure 108: India Export and Import Value & Volume, 2018-2019 ($)
Figure 109: Taiwan Colorectal Cancer MarketTaiwan 3D Printing Market Value & Volume, 2019-2024 ($)
Figure 110: Taiwan GDP and Population, 2018-2019 ($)
Figure 111: Taiwan GDP – Composition of 2018, By Sector of Origin
Figure 112: Taiwan Export and Import Value & Volume, 2018-2019 ($)
Figure 113: Malaysia Colorectal Cancer MarketMalaysia 3D Printing Market Value & Volume, 2019-2024 ($)
Figure 114: Malaysia GDP and Population, 2018-2019 ($)
Figure 115: Malaysia GDP – Composition of 2018, By Sector of Origin
Figure 116: Malaysia Export and Import Value & Volume, 2018-2019 ($)
Figure 117: Hong Kong Colorectal Cancer MarketHong Kong 3D Printing Market Value & Volume, 2019-2024 ($)
Figure 118: Hong Kong GDP and Population, 2018-2019 ($)
Figure 119: Hong Kong GDP – Composition of 2018, By Sector of Origin
Figure 120: Hong Kong Export and Import Value & Volume, 2018-2019 ($)
Figure 121: Middle East & Africa Colorectal Cancer MarketMiddle East & Africa 3D Printing Market Value & Volume, 2019-2024 ($)
Figure 122: Russia Colorectal Cancer MarketRussia 3D Printing Market Value & Volume, 2019-2024 ($)
Figure 123: Russia GDP and Population, 2018-2019 ($)
Figure 124: Russia GDP – Composition of 2018, By Sector of Origin
Figure 125: Russia Export and Import Value & Volume, 2018-2019 ($)
Figure 126: Israel Colorectal Cancer Market Value & Volume, 2019-2024 ($)
Figure 127: Israel GDP and Population, 2018-2019 ($)
Figure 128: Israel GDP – Composition of 2018, By Sector of Origin
Figure 129: Israel Export and Import Value & Volume, 2018-2019 ($)
Figure 130: Entropy Share, By Strategies, 2018-2019* (%)Colorectal Cancer Market
Figure 131: Developments, 2018-2019*Colorectal Cancer Market
Figure 132: Company 1 Colorectal Cancer Market Net Revenue, By Years, 2018-2019* ($)
Figure 133: Company 1 Colorectal Cancer Market Net Revenue Share, By Business segments, 2018 (%)
Figure 134: Company 1 Colorectal Cancer Market Net Sales Share, By Geography, 2018 (%)
Figure 135: Company 2 Colorectal Cancer Market Net Revenue, By Years, 2018-2019* ($)
Figure 136: Company 2 Colorectal Cancer Market Net Revenue Share, By Business segments, 2018 (%)
Figure 137: Company 2 Colorectal Cancer Market Net Sales Share, By Geography, 2018 (%)
Figure 138: Company 3Colorectal Cancer Market Net Revenue, By Years, 2018-2019* ($)
Figure 139: Company 3Colorectal Cancer Market Net Revenue Share, By Business segments, 2018 (%)
Figure 140: Company 3Colorectal Cancer Market Net Sales Share, By Geography, 2018 (%)
Figure 141: Company 4 Colorectal Cancer Market Net Revenue, By Years, 2018-2019* ($)
Figure 142: Company 4 Colorectal Cancer Market Net Revenue Share, By Business segments, 2018 (%)
Figure 143: Company 4 Colorectal Cancer Market Net Sales Share, By Geography, 2018 (%)
Figure 144: Company 5 Colorectal Cancer Market Net Revenue, By Years, 2018-2019* ($)
Figure 145: Company 5 Colorectal Cancer Market Net Revenue Share, By Business segments, 2018 (%)
Figure 146: Company 5 Colorectal Cancer Market Net Sales Share, By Geography, 2018 (%)
Figure 147: Company 6 Colorectal Cancer Market Net Revenue, By Years, 2018-2019* ($)
Figure 148: Company 6 Colorectal Cancer Market Net Revenue Share, By Business segments, 2018 (%)
Figure 149: Company 6 Colorectal Cancer Market Net Sales Share, By Geography, 2018 (%)
Figure 150: Company 7 Colorectal Cancer Market Net Revenue, By Years, 2018-2019* ($)
Figure 151: Company 7 Colorectal Cancer Market Net Revenue Share, By Business segments, 2018 (%)
Figure 152: Company 7 Colorectal Cancer Market Net Sales Share, By Geography, 2018 (%)
Figure 153: Company 8 Colorectal Cancer Market Net Revenue, By Years, 2018-2019* ($)
Figure 154: Company 8 Colorectal Cancer Market Net Revenue Share, By Business segments, 2018 (%)
Figure 155: Company 8 Colorectal Cancer Market Net Sales Share, By Geography, 2018 (%)
Figure 156: Company 9 Colorectal Cancer Market Net Revenue, By Years, 2018-2019* ($)
Figure 157: Company 9 Colorectal Cancer Market Net Revenue Share, By Business segments, 2018 (%)
Figure 158: Company 9 Colorectal Cancer Market Net Sales Share, By Geography, 2018 (%)
Figure 159: Company 10 Colorectal Cancer Market Net Revenue, By Years, 2018-2019* ($)
Figure 160: Company 10 Colorectal Cancer Market Net Revenue Share, By Business segments, 2018 (%)
Figure 161: Company 10 Colorectal Cancer Market Net Sales Share, By Geography, 2018 (%)
Figure 162: Company 11 Colorectal Cancer Market Net Revenue, By Years, 2018-2019* ($)
Figure 163: Company 11 Colorectal Cancer Market Net Revenue Share, By Business segments, 2018 (%)
Figure 164: Company 11 Colorectal Cancer Market Net Sales Share, By Geography, 2018 (%)
Figure 165: Company 12 Colorectal Cancer Market Net Revenue, By Years, 2018-2019* ($)
Figure 166: Company 12 Colorectal Cancer Market Net Revenue Share, By Business segments, 2018 (%)
Figure 167: Company 12 Colorectal Cancer Market Net Sales Share, By Geography, 2018 (%)
Figure 168: Company 13Colorectal Cancer Market Net Revenue, By Years, 2018-2019* ($)
Figure 169: Company 13Colorectal Cancer Market Net Revenue Share, By Business segments, 2018 (%)
Figure 170: Company 13Colorectal Cancer Market Net Sales Share, By Geography, 2018 (%)
Figure 171: Company 14 Colorectal Cancer Market Net Revenue, By Years, 2018-2019* ($)
Figure 172: Company 14 Colorectal Cancer Market Net Revenue Share, By Business segments, 2018 (%)
Figure 173: Company 14 Colorectal Cancer Market Net Sales Share, By Geography, 2018 (%)
Figure 174: Company 15 Colorectal Cancer Market Net Revenue, By Years, 2018-2019* ($)
Figure 175: Company 15 Colorectal Cancer Market Net Revenue Share, By Business segments, 2018 (%)
Figure 176: Company 15 Colorectal Cancer Market Net Sales Share, By Geography, 2018 (%)